FDA Drug Application (090825) for IMIPENEM AND CILASTATIN by HOSPIRA INC

Back to FDA Applications sponsored by HOSPIRA INC

Application Number090825
Product Number001
FormPOWDER;INTRAVENOUS
DosageEQ 250MG BASE/VIAL;250MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIMIPENEM AND CILASTATIN
Active IngredientCILASTATIN SODIUM; IMIPENEM

Active IngredientCount
List of drugs with Active Ingredient CILASTATIN SODIUM2
List of drugs with Active Ingredient IMIPENEM2


Back to FDA Applications sponsored by HOSPIRA INC